Announced Mon, 28 Jul · 16:58 IST

IOL Chemicals & Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2025 ,inter alia, to consider and approve the Un-Audited ....

IOLCP · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

IOL Chemicals & Pharmaceuticals has informed the stock exchanges that its Board of Directors will meet on Thursday, 7th August 2025 to consider and approve the Un-Audited Financial Results for the quarter ended 30th June 2025 (Q1 FY26). The company also confirmed that its trading window for designated persons, which has been closed since 1st July 2025, will remain shut until 48 hours after the results are announced and will reopen on 10th August 2025. No financial numbers or business details have been disclosed in this filing — it is purely an advance intimation under SEBI listing regulations.

Likely market impact

This is a routine regulatory disclosure and has no direct impact on the stock price. Investors should watch for the actual Q1 results on 7th–10th August 2025, which will reveal the company's quarterly revenue, profitability, and margin trends for the first quarter of FY26.